The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Measuring treatment-induced peripheral neuropathy in patients with cancer.
 
Tito R. Mendoza
Research Funding - Bayer; Bristol-Myers Squibb; Genentech
 
Loretta A. Williams
Consulting or Advisory Role - PledPharma
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bayer; Bristol-Myers Squibb; Genentech
 
Qiuling Shi
Research Funding - Bayer; Bristol-Myers Squibb
 
Xin Shelley Wang
Honoraria - Lilly (I); Merck (I); Merck Sharp & Dohme (I); Onconova Therapeutics (I); Pfizer (I)
Consulting or Advisory Role - Amgen (I); Astellas Pharma (I); AstraZeneca (I); Bristol-Myers Squibb (I); GlaxoSmithKline (I); Lilly (I); Merck (I); Merck Sharp & Dohme (I); Novartis (I); Onconova Therapeutics (I); Pfizer (I)
Research Funding - Bayer (I); Bristol-Myers Squibb; Genentech (I)
Travel, Accommodations, Expenses - Lilly (I); Merck (I); Merck Sharp & Dohme (I); Onconova Therapeutics (I); Pfizer (I)
 
Shireen Haq
Research Funding - Bayer
 
Nazim N Ali
Research Funding - Bayer; Genentech
 
Charles S. Cleeland
Honoraria - Lilly; Merck; Merck Sharp & Dohme; Onconova Therapeutics; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Merck Sharp & Dohme; Novartis; Onconova Therapeutics; Pfizer
Research Funding - Bayer (Inst); Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Bayer License agreement to use the MDASI (M D Anderson Symptom Inventory) (Inst)
Travel, Accommodations, Expenses - Lilly; Merck; Merck Sharp & Dohme; Onconova Therapeutics; Pfizer